Skip to main content
. 2024 May 28;15:1371393. doi: 10.3389/fendo.2024.1371393

Table 2.

Associations between the TyG index and endometriosis in the total cohort.

TyG index Cases with endometriosis/N OR (95% CI)
Crude a Model 1 b Model 2 c Model 3 d
Continuous Values
(7.049–11.951)
135/1,590 1.52 (1.17–1.97)* 1.53 (1.15–2.03)* 1.73 (1.26–2.36)* 1.62 (1.18–2.22)*
Quartile Categories
Q1 (7.049–8.061) 24/397 Reference Reference Reference Reference
Q2 (8.063–8.452) 31/398 1.31 (0.76–2.28) 1.29 (0.74–2.25) 1.35 (0.76–2.37) 1.26 (0.71–2.23)
Q3 (8.453–8.865) 33/398 1.41 (0.81–2.42) 1.35 (0.77–2.34) 1.42 (0.81–2.51) 1.31 (0.74–2.32)
Q4 (8.866–11.951) 47/397 2.09 (1.25–3.49)* 1.99 (1.16–3.40)* 2.27 (1.29–4.00)* 2.04 (1.15–3.62)*
P for trend 0.004 0.010 0.004 0.013

*Statistically significant association.

a

Crude model was adjusted for nothing.

b

Model 1 was adjusted for age, ethnicity, education level and marital status.

c

Model 2 included the covariates of Model 1 with additional adjustment for diabetes, body mass index and fertility status.

d

Model 3 included the covariates of Model 2 with additional adjustment for drinking status, smoking status and use of oral contraceptives.

TyG index, triglyceride-glucose index; OR, odds ratio; CI, confidence interval.